XRMI
Global X S&P 500 Risk Managed Income

68
Volume
7,060.00
52W High
$19.64
52W Low
$17.38
50D MA
$17.72
Prev Close
$17.80
Loading...
Loading...
News
all
press releases
News Placeholder
Biogen Licenses Vanqua Bio’s Immunology Drug In $1.06B Deal
Stocktwits·7d ago
News Placeholder
WST Stock Soars After Company Raises Full-Year Guidance On Strong Demand For GLP-1 Drug Components
Stocktwits·7d ago
News Placeholder
Humana Stock Rises After Insurer Reaffirms Full-Year Earnings Guidance
The firm also stated that its preliminary 2026 Medicare Advantage Star Ratings align with the assumptions in its financial planning, and as a result, there is no change to the incremental earnings potential for 2025 to 2028.
Stocktwits·28d ago

Latest XRMI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.